Site Logo
hero-heading

Creating a more personalized future of prostate cancer care.

home-hero-2x-crop

Clinical Need

1 in 8

men will develop prostate cancer

50%

of patients whose entire prostate is treated lose their sexual or urinary function

2x

increase in focal therapy research, yet determining where prostate cancer is remains a problem

3-Fold

underestimation by MRI of identifying the extent of prostate cancer disease

Solution

iQuest™

A New Way to Map Prostate Cancer

We use AI to visualize location and extent of prostate cancer to aid patients and their physicians in making informed decisions about their care.

Enabling personalized focal therapy for improved quality of life

Using iQuest cancer maps, cancerous tissue can be destroyed without impacting healthy tissue.  This focal approach can minimize complications including urinary incontinence and sexual dysfunction.

At Avenda Health, we believe patients should not have to choose between treating their prostate cancer and maintaining their quality of life.

man-woman-hugging

Recognition

Artboard 3

Granted Investigational Device Exemption by the FDA

Aug 2022

badge-fda-breakthrough

Granted Breakthrough Device Designation by the FDA

May 2021

badge-fda-cleared

Cleared by the FDA for Focal Laser Ablation System

Dec 2020

badge-focal-therapy

Voted “Most Promising Ablative Technology”

Oct 2020